Jim McGuire

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.

Aurum Biosciences Ltd. develops healthcare technology for pharmaceuticals innovation. It offers perfluorocarbon, magnetic resonance imaging (MRI), and proprietary image analysis software. The firm provides oxygen carrier as a novel stroke management product through combined diagnostic and therapeutic properties. It includes heart disease, cancer, epilepsy, and dementia. The company was founded by Dr Graeme Deuchar and Dr Celestine Santosh and is headquartered in Glasgow, the United Kingdom.